Soleno Therapeutics, Inc. (SLNO)
52.25
+12.76
(+32.31%)
USD |
NASDAQ |
Apr 06, 16:00
52.28
+0.03
(+0.06%)
After-Hours: 07:52
Soleno Therapeutics SG&A Expense (TTM) : 132.13M for Dec. 31, 2025
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Nektar Therapeutics | 68.67M |
| Integer Holdings Corp. | 211.75M |
| Boston Scientific Corp. | 6.888B |
| Molina Healthcare, Inc. | 0.00 |
| MannKind Corp. | 229.86M |